Numerous animal studies have demonstrated that elevated GC levels contribute to the pathophysiology of AD through several mechanisms, including increased Aβ deposition and tau protein hyperphosphorylation, chronic inflammation, and impairment of synaptic plasticity. Here, MAPT is linked to Alzheimer disease.